Optimization of a Self-microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat
Advanced Pharmaceutical Bulletin · 10.07.2023 · 13 (3) · 521-531
DOI: 10.34172/apb.2023.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 02.07.2022. Verfasst von Shahla Mirzaeei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nano Drug Delivery Research Centre, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
This study aimed to formulate Resveratrol, a practically water-insoluble antioxidant in a self-microemulsifying drug delivery system (SMEDDS) to improve the solubility, release rate, and intestinal permeability of the drug.
Methods
The suitable oil, surfactant, and co-surfactant were chosen according to the drug solubility study. Utilizing the design of experiment (DoE) method, the pseudo-ternary phase diagram was plotted based on the droplet size. In vitro dissolution study and the single-pass intestinal perfusion were performed for the investigation of in vitro and in-situ permeability for drugs formulated as SMEDDS in rat intestine using High-Performance Liquid Chromatography.
Results
Castor oil, Cremophor RH60, and PEG 1500 were selected as oil, surfactant, and co-surfactant. According to the pseudo-ternary phase diagram, nine formulations developed microemulsions with sizes ranging between 145-967 nm. Formulations passed the centrifuge and freeze-thaw stability tests. The optimum formulation possessed an almost 2.5-fold higher cumulative percentage of in vitro released resveratrol, in comparison to resveratrol aqueous suspension within 120 minutes. The results of the in-situ permeability study suggested a 2.6-fold higher intestinal permeability for optimum formulation than that of the resveratrol suspension.
Conclusions
SMEDDS can be considered suitable for the oral delivery of resveratrol according to the observed increased intestinal permeability, which could consequently enhance the bioavailability and therapeutic efficacy of the drug.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nano Drug Delivery Research Centre, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Pharmaceutical Sciences Research Centre, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Shahla Mirzaeei, Negar Tahmasebi, Ziba Islambulchilar
Zitieren
APA
Mirzaeei, S., Tahmasebi, N., & Islambulchilar, Z. (2023). Optimization of a Self-microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat. Advanced Pharmaceutical Bulletin, 13(3), 521-531. https://doi.org/10.34172/apb.2023.054
Vancouver
Mirzaeei S, Tahmasebi N, Islambulchilar Z. Optimization of a Self-microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat. Advanced Pharmaceutical Bulletin. 2023;13(3):521-531. doi:10.34172/apb.2023.054
BibTeX
@article{Mirzaeei2023,
author = {Mirzaeei, Shahla and Tahmasebi, Negar and Islambulchilar, Ziba},
title = {Optimization of a Self-microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat},
journal = {Advanced Pharmaceutical Bulletin},
year = {2023},
volume = {13},
number = {3},
pages = {521--531},
doi = {10.34172/apb.2023.054}
}
EUVIMED